| abstract |
The present invention relates to a composition capable of inhibiting the survival and proliferation of cancer cells, including an inhibitor of MYO1D (Myosin-1D) protein expression or activity as an active ingredient, and very effectively inhibits EGFR-related cell signaling activity in cancer cells. By doing so, it is possible to exhibit a remarkable effect in the prevention or treatment of cancer by suppressing the survival and proliferation of cancer cells. In addition, the MYO1D protein corresponds to a protein that is remarkably highly expressed only in cancer patients and cancer cells compared to the normal control, and provides information for effectively diagnosing cancer, thereby diagnosing cancer early to increase the therapeutic effect. have. |